GPNMB and hepatocellular carcinoma: Moreover, studies have shown that FTO expression is upregulated in hepatocellular carcinoma tumors, and targeting the FTO/m6A/GPNMB axis significantly inhibits tumor growth and metastasis while enhancing immune activation (Chen et al., 2024).